NCT07516925: A Study of Ivonescimab in People With Leiomyosarcoma
- State
- Under way
- Phase
- Phase 2
- People
- 20 planned
- Started
- 1 Apr 2026
- Primary completion
- Apr 2029
- Arms
- Ivonescimab
- Results
- None posted
- 1 Apr 2026: Trial started
- 8 Apr 2026: Trial registered